Total Payments
$46,215
2024 Payments
$31,586
Companies
23
Transactions
126
Medicare Patients
1,277
Medicare Billing
$323,803
Payment Breakdown by Category
Other$26,775 (57.9%)
Consulting$12,300 (26.6%)
Travel$3,709 (8.0%)
Food & Beverage$3,404 (7.4%)
Education$26.78 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,775 | 6 | 57.9% |
| Consulting Fee | $12,300 | 8 | 26.6% |
| Travel and Lodging | $3,709 | 17 | 8.0% |
| Food and Beverage | $3,404 | 93 | 7.4% |
| Education | $26.78 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $30,962 | 35 | $0 (2024) |
| Allergan, Inc. | $12,260 | 16 | $0 (2020) |
| EMD Serono, Inc. | $1,157 | 33 | $0 (2024) |
| Biogen, Inc. | $450.00 | 3 | $0 (2023) |
| Amgen Inc. | $229.26 | 4 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $172.80 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $148.33 | 4 | $0 (2018) |
| Stryker Corporation | $135.39 | 3 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $129.73 | 3 | $0 (2018) |
| Shire North American Group Inc | $122.21 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $31,586 | 43 | ABBVIE INC. ($30,879) |
| 2023 | $503.92 | 11 | Biogen, Inc. ($150.00) |
| 2022 | $191.31 | 7 | EMD Serono, Inc. ($114.23) |
| 2021 | $303.66 | 5 | Biogen, Inc. ($150.00) |
| 2020 | $12.61 | 1 | Allergan, Inc. ($12.61) |
| 2019 | $523.50 | 19 | EMD Serono, Inc. ($154.69) |
| 2018 | $365.77 | 5 | Amgen Inc. ($125.00) |
| 2017 | $12,727 | 35 | Allergan Inc. ($12,248) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $202.31 | General |
| 12/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $90.00 | General |
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| 12/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.00 | General |
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $102.44 | General |
| 11/14/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $50.71 | General |
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $241.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $83.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $217.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $98.77 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $12.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $1,202.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $120.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/02/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $87.10 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $10.25 | General |
| 05/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $7.24 | General |
| 05/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 299 | 11,742 | $318,620 | $84,329 |
| 2022 | 13 | 351 | 9,982 | $311,914 | $80,424 |
| 2021 | 13 | 335 | 10,854 | $319,029 | $86,021 |
| 2020 | 12 | 292 | 9,414 | $280,053 | $73,029 |
Total Patients
1,277
Total Services
41,992
Medicare Billing
$323,803
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 18 | 11,420 | $199,450 | $53,963 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $31,418 | $7,722 | 24.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 16 | 51 | $21,803 | $5,788 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 51 | $16,363 | $4,223 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 25 | $10,835 | $3,489 | 32.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 24 | 24 | $10,800 | $2,438 | 22.6% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 29 | 29 | $10,928 | $2,212 | 20.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 25 | 25 | $6,785 | $1,752 | 25.8% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 28 | 30 | $5,280 | $1,388 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 23 | $4,958 | $1,354 | 27.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 16 | 9,605 | $167,290 | $44,517 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $35,426 | $8,913 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 59 | $18,917 | $5,244 | 27.7% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 13 | 44 | $18,816 | $4,670 | 24.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $14,537 | $3,228 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 39 | $8,445 | $2,419 | 28.6% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 27 | 27 | $10,384 | $2,323 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $8,706 | $2,138 | 24.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 25 | 26 | $7,144 | $1,886 | 26.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 21 | 21 | $9,447 | $1,761 | 18.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 13 | $5,599 | $1,406 | 25.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 25 | 27 | $4,812 | $1,315 | 27.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 11 | $2,391 | $602.56 | 25.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 22 | 10,501 | $178,816 | $49,446 | 27.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 50 | 50 | $30,850 | $8,014 | 26.0% |
About Dr. Darshan Shah, MD
Dr. Darshan Shah, MD is a Neurology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1144423872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Darshan Shah, MD has received a total of $46,215 in payments from pharmaceutical and medical device companies, with $31,586 received in 2024. These payments were reported across 126 transactions from 23 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($26,775).
As a Medicare-enrolled provider, Shah has provided services to 1,277 Medicare beneficiaries, totaling 41,992 services with total Medicare billing of $323,803. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Austin, TX
- Active Since 06/08/2007
- Last Updated 03/08/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1144423872
Products in Payments
- BOTOX (Biological) $43,038
- TYSABRI (Biological) $450.00
- Aimovig (Biological) $192.00
- BOTOX CHRONIC MIGRAINE (Drug) $143.34
- Rebif (Biological) $142.15
- PRIME SERIES (Device) $135.39
- GILENYA (Drug) $134.83
- GAMMAGARD (Biological) $122.21
- AUSTEDO (Drug) $121.38
- NUEDEXTA (Drug) $88.10
- MAVENCLAD (Drug) $81.15
- VYVGART (Drug) $77.08
- FORTEO (Drug) $53.93
- AJOVY (Drug) $51.42
- TROKENDI XR (Drug) $50.04
- ONZETRA Xsail (Drug) $41.63
- Briviact (Drug) $41.35
- Mavenclad (Biological) $38.26
- Prolia (Biological) $37.26
- GELSYN 3 (Device) $35.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Austin
Dr. Elliot Frohman, Md Phd, MD PHD
Neurology — Payments: $633,909
Neurology $633,909
Dr. David Morledge, M.d, M.D
Neurology — Payments: $180,453
Neurology $180,453
Dr. Sami Aboumatar, M.d, M.D
Neurology — Payments: $159,184
Neurology $159,184
Dr. Subhashie Wijemanne, M.d, M.D
Neurology — Payments: $140,816
Neurology $140,816
Dr. Krishna Pokala, Md, MD
Neurology — Payments: $103,512
Neurology $103,512
Dr. Rajat Gupta, M.d, M.D
Neurology — Payments: $91,931
Neurology $91,931